What Is a SAFE Note (Simple Agreement for Future Equity) in the UK?

Raising early-stage capital can feel daunting when you’re still refining your product and don’t want to lock in a valuation too early. That’s where a “SAFE note” is often mentioned - a quick, founder-friendly way to bring in cash now and issue equity later.

But what is a SAFE note, how does it actually work in the UK, and is it the right fit for your business? In this guide, we’ll demystify the essentials, highlight the UK-specific legal and tax wrinkles, and share practical steps to use SAFEs (or UK equivalents) well - so you can raise money with confidence and protect your cap table as you grow.

What Is A SAFE Note And How Does It Work?

A SAFE note (Simple Agreement for Future Equity) is a short contract used by startups to raise money now in return for the promise of issuing shares later - usually when you do a priced equity round. Unlike a convertible loan note, a SAFE:

• Isn’t debt (no interest, no fixed repayment, typically no maturity date).
• Converts into shares in the future on predefined “conversion events”.
• Often includes a valuation cap and/or discount to reward early risk.

It was popularised in the US by Y Combinator. In the UK, SAFEs exist in practice, but many investors and advisors prefer the UK-flavoured equivalent - an Advanced Subscription Agreement (ASA). An ASA also provides funding now for future equity, but it’s structured to better fit UK company law and tax frameworks.

At a high level, here’s what happens with a typical SAFE:

1. You and an investor sign a short agreement setting out the funding amount and conversion mechanics.
2. The investor transfers the cash immediately.
3. No shares are issued on day one, so you avoid setting a valuation prematurely.
4. On a future “equity financing” (your next priced round), the SAFE converts into shares at either a discounted price or a price derived from the valuation cap, whichever gives the investor a better outcome under the agreed terms.
5. Conversion can also be triggered by other events you define (e.g. a sale of the company or long-stop date).

Done well, this speeds up early fundraising and keeps legal costs down compared with a full priced round.

SAFE Vs ASA In The UK: What’s The Difference?

In the UK, both instruments aim to delay valuation and streamline an early raise. Key differences you’ll see in practice:

• Debt vs equity character: A classic SAFE is a contractual right to future equity, not a loan. An ASA is generally treated as a genuine subscription for shares to be issued later (prepayment for equity), which can be important for UK tax treatment.
• SEIS/EIS compatibility: SAFEs often don’t qualify for SEIS/EIS relief - a major drawback for UK angel investors. ASAs may be compatible if structured carefully (e.g. no investor-friendly “debt-like” features, conversion within a reasonable period). Always seek tax advice early.
• Market familiarity: Many UK investors, accountants and tax advisors are more familiar with ASA mechanics, timetables and HMRC expectations.

Practically, founders raising in the UK should consider whether an ASA will achieve the same goal with fewer downstream complications. If you do opt for a US-style SAFE, make sure it’s adapted for UK company law and investor expectations. If you’d like a short, founder-friendly template tailored to your round, our team can prepare a bespoke SAFE Note or ASA to suit your deal.

Key Terms To Negotiate In A SAFE Note

Even though a SAFE looks short, the commercial levers matter. Common terms include:

Valuation Cap

The maximum company valuation used to calculate the investor’s conversion price, regardless of the actual valuation in the priced round. A lower cap gives the investor more shares on conversion. Example: If your cap is £5m and your next round values you at £10m, the SAFE converts as if you were valued at £5m.

Discount

An agreed percentage reduction to the share price paid by new investors in the priced round (e.g. 15–25%). Some SAFEs have a cap, some a discount, some both (the investor benefits from the better outcome at conversion).

Most Favoured Nation (MFN)

Gives the investor the option to adopt more favourable terms you offer in later SAFEs before conversion. This protects early investors if you issue a subsequent SAFE with sweeter terms.

Pro Rata Rights

A right to participate in future rounds to maintain ownership percentage. Useful to agree up front so there’s clarity on allocations at the next raise.

Conversion Triggers

Define when the SAFE converts to equity. Typical triggers are:

• Equity financing: your next priced round over a set minimum raise amount.
• Change of control: sale or merger (conversion to shares then proceeds, or a cash-out formula).
• Long-stop date: at a certain date, convert at a default price or on latest valuation - UK ASAs often include 6–12 month windows.

Share Class On Conversion

Will the SAFE convert into the same class issued in the priced round (often preferred shares), or into ordinary shares with an economic equivalent? You may need to update your Articles of Association to reflect any new class rights.

Legal And Tax Considerations Under UK Law

Before signing a SAFE or ASA, it’s important to understand the UK-specific legal and tax context.

Companies Act 2006 Authorities And Filings

• Authority to allot: Directors need valid shareholder authority to allot new shares (Companies Act 2006 s551). This is typically renewed annually.
• Pre-emption rights: Existing shareholders may have statutory pre-emption rights on new issues (s561). If relevant, you may need a special resolution to disapply these rights (s570).
• Share class rights: If conversion will result in preferred shares, ensure your constitutional documents authorise the class and set out rights (dividends, liquidation preference, anti-dilution, voting). Amending the Articles of Association often forms part of the round prep.
• SH01: When shares are actually allotted (on conversion), you must file Form SH01 within one month and update your statutory registers and cap table.

It’s common to put in place the necessary shareholder approvals via written resolutions prior to issuing or converting instruments. If you need a simple template to formalise board approvals, you can use professionally drafted directors’ resolutions to keep things tidy.

Financial Promotion Rules (FCA)

Marketing investments is heavily regulated in the UK under the Financial Services and Markets Act 2000. Unless you are an FCA-authorised firm (most startups aren’t), you should only make “financial promotions” (i.e. inviting or inducing investment) to exempt categories (e.g. certified high net worth or sophisticated investors) and keep communications within permitted exemptions. Many founders work with networks or platforms who handle investor categorisation and risk warnings - it’s critical you comply.

SEIS/EIS Eligibility

Many UK angels expect SEIS/EIS tax relief. Classic SAFEs can be problematic because investors aren’t subscribing for shares at the time and certain terms may look “debt-like”. An ASA can be structured to be more compatible, but there are still important criteria (e.g. genuine advance subscription, no investor discretion to demand repayment, typical conversion within 6 months, and other HMRC expectations). Get specialist tax advice early and consider obtaining HMRC advance assurance where appropriate.

Accounting And Tax

• Company accounts: The instrument may be presented differently under accounting standards depending on terms (equity vs liability classification).
• Stamp duty: There’s no stamp duty on the issue of new shares on conversion, but future transfers of shares can attract stamp duty.
• Employee incentives: Keep headroom for team incentives. Using EMI options can be tax-efficient and should be factored into your cap table planning alongside SAFEs/ASAs.

Finally, coordinate the SAFE/ASA with your investor documents at the priced round - your Shareholders Agreement and updated constitution will set the rights those converting investors ultimately receive.

Common Pitfalls (And How To Avoid Them)

SAFEs and ASAs are designed to be simple - but simplicity can hide risk. Watch out for these issues:

• Stacking multiple SAFEs with different terms: If you sign several instruments with varying caps, discounts or MFN rights, your cap table can become unpredictable. Maintain a single “most favoured” set of terms where possible or track each instrument meticulously with clear modelling.
• Unclear or unrealistic conversion triggers: Vague long-stop dates or “any fundraising” triggers can cause disputes. Define objective triggers (e.g. minimum raise size, deadline, and what happens if it isn’t met).
• No share class planning: Promising “the next round’s preferred” without preparing class rights can delay your round. Line up your Articles of Association updates in advance.
• MFN overreach: A broad MFN clause can unintentionally re-open negotiation on every later instrument. Consider limiting MFN to economic terms only (cap/discount) and excluding protective provisions.
• SEIS/EIS missteps: If investors expect relief, a US-style SAFE with debt-like features can jeopardise eligibility. Consider an ASA structured in line with HMRC practice.
• Financial promotion breaches: Blasting investment invites publicly or to retail investors can trigger regulatory risk. Keep promotions within exemptions and maintain appropriate investor certifications.
• Founder dilution surprises: A low cap might feel fine now but could cause severe dilution on conversion. Model outcomes under multiple scenarios before signing.

If you’re unsure how a term will play out, run the numbers. A simple cap table model showing ownership pre- and post-conversion (with various round sizes and valuations) is worth its weight in gold.

Step-By-Step: Using A SAFE Or ASA In Your UK Raise

1) Map Your Raise Strategy

Decide how much you’re raising, from whom, and what instrument fits the investor base. If angels want SEIS/EIS, you’ll likely lean toward an ASA. If your investors are comfortable with a properly adapted SAFE, that can also work.

2) Capture The Deal On One Page

Before lawyering up, align on the key economics in a simple Term Sheet: amount, valuation cap, discount, MFN, conversion triggers, share class on conversion, and pro rata rights. This saves time later.

3) Prepare The Instrument

Work with a lawyer to prepare a founder-friendly SAFE Note or an ASA that reflects UK company law and your commercial terms. Avoid generic templates - tailored drafting prevents nasty edge cases and aligns with your constitution and future round documents.

4) Get Corporate Authorities In Place

Put the necessary board and shareholder approvals in place for the issue and future conversion, including authority to allot and any disapplication of pre-emption rights. Use formal directors’ resolutions and shareholder resolutions to keep your records clean.

5) Close, Bank, Record

Sign the documents, receive funds, and log the instrument on your cap table. Communicate clearly with investors about next steps and expected timelines for conversion events.

6) Plan For The Priced Round

When you’re ready for a priced round, update your Articles of Association, put your Shareholders Agreement in place, and model how each instrument will convert. File SH01s promptly post-allotment and update statutory registers.

What Happens On Conversion?

When a conversion event occurs (say you raise £2m at a £10m pre-money valuation), each SAFE or ASA converts according to its terms. For example:

• With a 20% discount and no cap, the conversion price would be 80% of the round price.
• With a £5m valuation cap and no discount, the conversion price would reflect the cap (i.e. half the price paid by new investors in the £10m round).
• If both a cap and discount are present, the investor typically gets the better outcome.

After conversion, investors become shareholders with the agreed class rights. You’ll then complete the usual equity round formalities, including updating Companies House filings, statutory registers, and your cap table. If you’re introducing employee equity alongside the round, consider granting EMI options in parallel so you don’t lose momentum on hiring.

Which Instrument Is Best For My Business?

There’s no one-size-fits-all answer. Consider:

• Investor expectations: If angels want SEIS/EIS, an ASA is often more suitable.
• Speed and simplicity: Both a well-drafted SAFE and ASA can be quick to close; pick the one your investor base understands.
• Future-proofing: Ensure your instrument plays nicely with your next round’s documents (preferred share terms, liquidation preference, information rights, etc.).
• Cap table clarity: Model dilution under different scenarios before you agree a cap or discount.

If you’re planning multiple instruments before a priced round, adopt consistent terms where possible and keep meticulous records. A centralised summary of all outstandings (amount, date, cap/discount, MFN, pro rata) will save you time and cost at the next raise.

Essential Documents To Line Up

To stay organised and protected from day one, we recommend having the following in place around your SAFE/ASA raise:

• Term Sheet capturing the headline deal.
• The instrument itself - a UK-adapted SAFE Note or ASA.
• Board and shareholder approvals, including authority to allot and disapplication of pre-emption where relevant (implemented via formal directors’ resolutions and written shareholder resolutions).
• Updated Articles of Association to create or refine any new share classes used on conversion.
• Post-round core equity documents, including a robust Shareholders Agreement setting out investor protections, founder vesting, board composition and information rights.
• Employee incentives plan and headroom, often via tax-efficient EMI options.

Avoid generic templates - these documents should align with each other and your future fundraising plans.

Key Takeaways

• A SAFE note is a fast way to raise funds now for future equity, but in the UK many investors prefer an ASA because it aligns better with company law and potential SEIS/EIS relief.
• Focus on the key economics: valuation cap, discount, MFN and clear conversion triggers. Model dilution under multiple scenarios before you agree terms.
• Make sure you have the right corporate approvals, respect pre-emption rights, and update your constitutional documents so conversion is smooth.
• Be careful with financial promotion rules - target exempt investor categories or work with authorised partners to stay compliant.
• Coordinate your instrument with your priced round documents: update your Articles of Association, adopt a strong Shareholders Agreement, and file SH01s after allotment.
• If SEIS/EIS is important to your investors, consider using an ASA and obtain tax advice early to avoid jeopardising relief.
• Keep your cap table clean, terms consistent where possible, and records meticulous - it will save time and cost at the next round.

If you’d like help choosing and drafting the right instrument for your raise - from a UK-adapted SAFE to an ASA - you can reach us at 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.